- Home
- SAGE vs CIX Comparison
SAGE vs CIX Comparison
Compare SAGE & CIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAGE
- CIX
- Stock Information
- Founded
- SAGE 2010
- CIX 1993
- Country
- SAGE United States
- CIX United States
- Employees
- SAGE N/A
- CIX N/A
- Industry
- SAGE Biotechnology: Pharmaceutical Preparations
- CIX Industrial Machinery/Components
- Sector
- SAGE Health Care
- CIX Consumer Discretionary
- Exchange
- SAGE Nasdaq
- CIX Nasdaq
- Market Cap
- SAGE 462.2M
- CIX 411.4M
- IPO Year
- SAGE 2014
- CIX 1998
- Fundamental
- Price
- SAGE $6.94
- CIX $26.59
- Analyst Decision
- SAGE Hold
- CIX
- Analyst Count
- SAGE 20
- CIX 0
- Target Price
- SAGE $11.39
- CIX N/A
- AVG Volume (30 Days)
- SAGE 2.8M
- CIX 10.7K
- Earning Date
- SAGE 02-12-2025
- CIX 02-26-2025
- Dividend Yield
- SAGE N/A
- CIX 4.51%
- EPS Growth
- SAGE N/A
- CIX N/A
- EPS
- SAGE N/A
- CIX 1.52
- Revenue
- SAGE $106,399,000.00
- CIX $150,690,000.00
- Revenue This Year
- SAGE N/A
- CIX N/A
- Revenue Next Year
- SAGE $122.32
- CIX N/A
- P/E Ratio
- SAGE N/A
- CIX $17.44
- Revenue Growth
- SAGE 837.60
- CIX N/A
- 52 Week Low
- SAGE $4.62
- CIX $20.60
- 52 Week High
- SAGE $27.68
- CIX $39.91
- Technical
- Relative Strength Index (RSI)
- SAGE 60.28
- CIX 49.47
- Support Level
- SAGE $6.75
- CIX $23.41
- Resistance Level
- SAGE $7.88
- CIX $26.77
- Average True Range (ATR)
- SAGE 0.38
- CIX 0.83
- MACD
- SAGE 0.13
- CIX 0.21
- Stochastic Oscillator
- SAGE 64.39
- CIX 88.58
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.
About CIX CompX International Inc.
Compx International Inc is a manufacturer of security products. Its security products are used in recreational transportation, postal, office & institutional furniture, cabinetry, tool storage, healthcare, and a variety of other industries. Also, it is engaged in the manufacturing of stainless steel exhaust systems, gauges, throttle controls, and trim tabs for the recreational marine industry. The company's operating segment includes Security Products and Marine Components. The company generates maximum revenue from the Security Products segment, which manufactures mechanical and electrical cabinet locks and other locking mechanisms. Its geographical segments are the United States, Canada, Mexico, and others, of which the United States accounts for the vast majority of revenue.